|
EconStor >
Forschungsinstitut zur Zukunft der Arbeit (IZA), Bonn >
IZA Discussion Papers, Forschungsinstitut zur Zukunft der Arbeit (IZA) >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/20642
|
| | |
Full metadata record
| DC Field | | Value | | Language |
| dc.contributor.author | | Alan, Sule | | en_US |
| dc.contributor.author | | Crossley, Thomas F. | | en_US |
| dc.contributor.author | | Grootendorst, Paul | | en_US |
| dc.contributor.author | | Veall, Michael R. | | en_US |
| dc.date.accessioned | | 2009-01-28T16:15:37Z | | - |
| dc.date.available | | 2009-01-28T16:15:37Z | | - |
| dc.date.issued | | 2003 | | en_US |
| dc.identifier.uri | | http://hdl.handle.net/10419/20642 | | - |
| dc.description.abstract | | Canadian household prescription drug expenditures are studied using different years of the Statistics Canada Family Expenditure Survey. Master files are used, expanding the number of available years and permitting provincial rather than regional identifiers. Nonparametric Engel curves are estimated. Difference-in-difference mean and 80th percentile regressions examine budget shares by low-income and high-income households before and after the introduction of provincial prescription drug programs. The evidence is consistent with the view that unlike senior prescription drug subsidies, nonsenior prescription drug subsidies are probably more redistributive than an equal-cost proportional income transfer. | | en_US |
| dc.language.iso | | eng | | en_US |
| dc.publisher | | | | en_US |
| dc.relation.ispartofseries | | IZA Discussion paper series 695 | | en_US |
| dc.subject.jel | | J42 | | en_US |
| dc.subject.jel | | I18 | | en_US |
| dc.subject.ddc | | 330 | | en_US |
| dc.subject.keyword | | prescription drug benefits | | en_US |
| dc.subject.keyword | | incidence | | en_US |
| dc.subject.stw | | Drogenkonsum | | en_US |
| dc.subject.stw | | Verbraucherausgaben | | en_US |
| dc.subject.stw | | Drogenpolitik | | en_US |
| dc.subject.stw | | Subvention | | en_US |
| dc.subject.stw | | Schätzung | | en_US |
| dc.subject.stw | | Kanada | | en_US |
| dc.title | | Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs | | en_US |
| dc.type | | Working Paper | | en_US |
| dc.identifier.ppn | | 362046697 | | en_US |
| dc.rights | | http://www.econstor.eu/dspace/Nutzungsbedingungen | | - |
| Appears in Collections: | | IZA Discussion Papers, Forschungsinstitut zur Zukunft der Arbeit (IZA)
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|